Home > Insider Trading > Anacor Pharmaceuticals Inc.

Anacor Pharmaceuticals Inc. (ANAC)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

What Hedge Funds Think Of Goldman Sachs' Top Healthcare Takeover Targets

A surge of M&A activity involving healthcare, financial, and retail companies boosted the value of deals in July to over $430 billion, resulting in the seventh-busiest month on record in terms of value...

Keep Reading →

September 12th, 2015 - Hedge Funds Market Movers News

These Hot Healthcare Stocks Lead Palo Alto Investors' Picks To Big Q2 Returns

William Leland Edwards' Palo Alto Investors is a reputable fund with a strong focus and in-depth knowledge of healthcare stocks, a sector that accounts for more than 80% of its total holdings.

Keep Reading →

July 17th, 2015 - Hedge Fund Analysis Hedge Funds News

Another Score For Baker Bros. As Anacor Pharmaceuticals Inc (ANAC) Soars 65% Premarket On Crisaborole Trial Success

Shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) soared to a lofty $140.00 per share pre-market high today, or a whopping 65.47% higher than the stock’s closing price of $84.61 on Friday after the...

Keep Reading →

July 13th, 2015 - Hedge Funds News

Abercrombie & Fitch Co., Anacor Pharmaceuticals Inc and Civeo Corp (CVEO): Latest Insider Action

Insider trades can provide additional information about where the company's management or large shareholders (those having larger than 10% stake in the company) see the share price heading.

Keep Reading →

March 26th, 2015 - Insider Trading News

Juno Therapeutics Inc (JUNO), Anacor Pharmaceuticals Inc (ANAC): VHCP Management’s Top 3 Biotech Picks

Andres Hove and Bong Koh’s VHCP Management revealed its top 3 biotech picks heading into 2015, in a 13F Form filed with the U.S. Securities and Exchange Commission last month.

Keep Reading →

March 2nd, 2015 - Hedge Funds News

Avalanche Biotechnologies Inc (AAVL), Anacor Pharmaceuticals Inc (ANAC), DBV Technologies, Boulogne-Billancourt (DBVT): Among Venrock's Top Succesful Biotech Plays

Venrock Healthcare Capital Partners is a fund that is focused entirely on the healthcare sector, mainly on the biotech sector.

Keep Reading →

November 26th, 2014 - Hedge Funds News

How One Anacor Pharmaceuticals Insider is Making Bank

Anacor Pharmaceuticals, Geoffrey Parker: In a recent Form 4 filing with the SEC, M.

Keep Reading →

October 7th, 2013 - Insider Trading News

Animal Health Industry: Michael Castor's Next Promising Pick Is Here

Animal health industry: There are hundreds of different "investment gurus" lauded by the financial press as the names retail investors should pay attention to.

Keep Reading →

September 21st, 2013 - Hedge Funds News

Cardinal Health, Inc. (CAH), NPS Pharmaceuticals, Inc. (NPSP), Anacor Pharmaceuticals Inc (ANAC): Checking Back In On Michael Castor's Favorite Healthcare Trio

A few healthcare companies Castor has mentioned he's liked this year are: Cardinal Health, Inc. (NYSE:CAH), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), and Anacor Pharmaceuticals Inc (NASDAQ:ANAC).

Keep Reading →

September 5th, 2013 - Hedge Funds

Chimera Investment Corporation (CIM), Freeport-McMoRan Copper & Gold Inc. (FCX), Anacor Pharmaceuticals Inc (ANAC): What This $5 Billion Hedge Fund Has Been Buying

The biggest new holdings are Charter Communications and Smithfield Foods. Other new holdings of interest include Chimera Investment Corporation (NYSE:CIM).

Keep Reading →

September 4th, 2013 - Hedge Funds News